Procedure
renal sympathetic modification
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Other(4)
Detailed Status
unknown4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
unknown4100%
Recent Activity
0 active trials
Showing 4 of 4
unknownnot_applicable
Renal Sympathetic Modification in Patients With Essential Hypertension
NCT01417221
unknownnot_applicable
Renal Sympathetic Modification in Patients With Heart Failure
NCT01402726
unknownnot_applicable
Renal Sympathetic Modification in Patients With Metabolic Syndrome
NCT01417247
unknownnot_applicable
Renal Sympathetic Modification in Patients With Chronic Renal Failure
NCT01418560
Clinical Trials (4)
Showing 4 of 4 trials
NCT01417221Not Applicable
Renal Sympathetic Modification in Patients With Essential Hypertension
NCT01402726Not Applicable
Renal Sympathetic Modification in Patients With Heart Failure
NCT01417247Not Applicable
Renal Sympathetic Modification in Patients With Metabolic Syndrome
NCT01418560Not Applicable
Renal Sympathetic Modification in Patients With Chronic Renal Failure
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4